CAAS
DGX icon

Capital Asset Advisory Services’s Quest Diagnostics DGX Stock Holding History

Capital Asset Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,341
Closed -$178K – 487
2022
Q2 		$178K Buy
+1,341
New +$183K 0.02% 376
2021
Q1 		– Sell
-882
Closed -$105K – 868
2020
Q4 		$105K Buy
+882
New +$108K 0.02% 445

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Asset Advisory Services's DGX Position: Q3 2022 in Review

Capital Asset Advisory Services sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 1,341 shares — an estimated $178K sold.

Capital Asset Advisory Services first reported a position in DGX in Q4 2020 and held it in 2 quarters. The position peaked at $178K in Q2 2022. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Capital Asset Advisory Services reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Capital Asset Advisory Services sold 1,341 Quest Diagnostics shares in Q3 2022, an estimated $178K.
  • Capital Asset Advisory Services first reported a position in Quest Diagnostics in Q4 2020 and held it in 2 quarters.
  • Capital Asset Advisory Services's Quest Diagnostics position peaked at $178K in Q2 2022.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Capital Asset Advisory Services's 13F filing for Q3 2022, filed 14 Nov 2022.